<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Ibuprofen - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Ibuprofen</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Analgesia / Anti-inflammatory</div>
      <h1>Ibuprofen</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Ibuprofen 400mg Tablets</li>
          <li>Ibuprofen 600mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Pain/fever (typical short-term use)</strong>
            <ul>
              <li>400 mg PO every 6–8 hours as needed</li>
              <li>If needing higher single doses and appropriate for patient risk: 600 mg PO every 8 hours as needed</li>
              <li>Use the lowest effective dose for the shortest duration</li>
            </ul>
          </li>
          <li><strong>Anti-inflammatory dosing (selected cases)</strong>
            <ul>
              <li>600 mg PO every 8 hours short-term when needed (reassess frequently)</li>
            </ul>
          </li>
          <li><strong>Maximum daily dose (practical onboard guidance)</strong>
            <ul>
              <li>Avoid high-dose regimens in higher-risk patients; do not exceed 2400 mg/day without clear indication and careful risk assessment</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Mild to moderate pain (MSK pain, dental pain, headache)</li>
          <li>Fever</li>
          <li>Inflammatory pain (sprains/strains; selected arthritis flares)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>NSAID hypersensitivity (including ASA-exacerbated respiratory disease)</li>
          <li>Active GI bleeding or active peptic ulcer disease</li>
          <li>Significant renal impairment/dehydration or deteriorating renal function</li>
          <li>Severe heart failure or significant cardiovascular disease/risk (higher doses increase risk)</li>
          <li>Pregnancy: avoid in 3rd trimester; use caution/avoid from ~20 weeks onward per warnings; follow local guidance</li>
          <li>Concomitant anticoagulants/antiplatelets, heavy alcohol use, older age → higher bleeding risk</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Dyspepsia, nausea</li>
          <li>GI ulceration/bleeding</li>
          <li>Fluid retention, ↑BP; renal function decline (especially with dehydration/ACEi/diuretics)</li>
          <li>Cardiovascular thrombotic events risk increases with higher dose/duration</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Take with food or milk if GI upset</li>
          <li>Avoid stacking with other NSAIDs (naproxen, ketorolac, etc.)</li>
          <li>If patient is on low-dose ASA for CV prevention, coordinate timing per local guidance (ibuprofen can interfere with ASA antiplatelet effect)</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom relief and ongoing need (stop when no longer needed)</li>
          <li>GI symptoms (melena, hematemesis, severe epigastric pain)</li>
          <li>BP/edema (if at risk)</li>
          <li>Renal risk: ensure hydration; consider renal function monitoring when feasible in higher-risk patients</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Dehydration/heat stress increases renal/GI risk—prioritize hydration and limit NSAID exposure</li>
          <li>If limited labs, be conservative in older patients, those with renal disease, or on ACEi/ARB/diuretics</li>
          <li>Document dose/time carefully to avoid "double-dosing" with other NSAIDs onboard</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (ibuprofen tablets): <a href="https://pdf.hres.ca/dpd_pm/00073493.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00073493.PDF</a></li>
          <li>Health Canada product monograph (ibuprofen – alternate monograph): <a href="https://pdf.hres.ca/dpd_pm/00055980.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00055980.PDF</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
